Djordje Miladinovic

Currently

Working at GSK on drug discovery, since 2021.

I develop machine learning tools to analyze and process high-dimensional, multi-modal high-throughput experimental data, unlocking insights and driving innovation in preclinical drug discovery. I am building foundational models designed to enable robust, accurate, and interpretable identification of genetic targets critical for understanding and treating diseases.

• [2017-2021] Obtained AI/ML-focused PhD from ETH Zürich with Prof. Joachim. M. Buhmann. During my time at ETH, I collaborated with Swiss AI lab IDSIA led by Prof. Jürgen Schmidhuber and with the Max Planck Institute for Intelligent Systems led by Prof. Bernhard Schölkopf.
• [2016-2017] Interned in Logitech – applied AI/ML to user profiling.
• [2015-2016] Worked in Disney Research on signal processing in robotics.
• [2013-2016] MS from ETH Zürich, in computer science.
• [2009-2013] BS from the University of Belgrade, in computer science.

• Problem-oriented R&D of AI/ML methodology with measurable societal impact.
• Foundational models for multi-modal and high-dimensional data.
• Meticulous, viable, clean, re-usable software development – I expect engineering to be of central importance in most major advances that are yet to come in AI/ML.
• Organizing and taking large projects from concept to working system.